Alx Oncology Holdings (ALXO) Asset Utilization Ratio (2020 - 2021)

Alx Oncology Holdings (ALXO) posted Asset Utilization Ratio of 0.0 for Q1 2021, down 64.16% sequentially from 0.0 in Q4 2020.

Analysis

Alx Oncology Holdings (ALXO) Asset Utilization Ratio (2020 - 2021) Analysis & Trends

Alx Oncology Holdings has reported Asset Utilization Ratio for 2 years, with the latest figure at 0.0 in Q1 2021.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was 0.0 (changed N/A YoY) and the FY2020 annual result came in at 0.01, changed N/A from the prior year.
Asset Utilization Ratio retreated to 0.0 in Q1 2021 per ALXO's latest filing, from 0.0 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 0.01 in Q3 2020 and troughed at 0.0 in Q1 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	139.31 Bn	131.46 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.65 Bn	77.66 Bn	3.93 Bn	0.38
3	Argenx Se	63.46 Bn	58.27 Bn	1.37 Bn	-
4	Moderna	57.94 Bn	52.80 Bn	52.00 Mn	0.20
5	Revolution Medicines	44.05 Bn	44.05 Bn	-	-
6	BeOne Medicines	39.96 Bn	34.86 Bn	1.53 Bn	0.69
7	Alnylam Pharmaceuticals	35.16 Bn	31.85 Bn	992.69 Mn	0.90
8	Royalty Pharma	28.44 Bn	27.60 Bn	-	0.13
9	Insmed	27.32 Bn	26.16 Bn	358.27 Mn	0.54
10	Alx Oncology Holdings	274.67 Mn	274.67 Mn	-	-

Historic Data

Download Data